SCHEMBL2834645

SCHEMBL2834645

COc1cc(C)c(S(=O)(=O)N2c3ccccc3C[C@H]2COc2ccnc(N(C)CCN3CCC(c4ccccc4)(N4CCCC4)CC3)n2)c(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2839331 0.91 TSHR (0.33)
SCHEMBL2831976 0.89
SCHEMBL2833635 0.87 TSHR (0.32)
SCHEMBL2836406 0.87 CASP3 (0.35)
SCHEMBL2839370 0.87 CASP3 (0.34)
SCHEMBL2834641 0.86 NPY1R (0.31)
SCHEMBL2832189 0.86 LMNA (0.33)
SCHEMBL2835616 0.82 NAAA (0.30)
SCHEMBL2832121 0.81 BDKRB1 (0.42)
SCHEMBL2831973 0.81 NPY5R (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356101-B1 PYRIMIDINE- AND TRIAZINE-SULFONAMIDE DERIVATIVES AS BRADYKININ B1 RECEPTOR (B1R) INHIBITORS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2013-02-27 EP claimed
US-8269000-B2 Substituted pyrimidine and triazine compounds GRUENENTHAL GMBH (DE) 2012-09-18 US claimed
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds GRUENENTHAL GMBH (DE) 2010-07-08 US claimed
US-8269000-B2 Substituted pyrimidine and triazine compounds GRUENENTHAL GMBH (DE) 2012-09-18 US disclosed
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds GRUENENTHAL GMBH (DE) 2010-07-08 US disclosed